Participants
Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder, ADHD
Data were obtained from a healthy population taking part in a clinical trial for the development of treatments for Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD) based on tDCS. The study was approved by the local ethics committee of the Medical Faculty at Kiel University, Germany, and was carried out in accordance with the latest revision of the Declaration of Helsinki and registered in the German Trial Register with number DRKS00008207.A total of N=56 children and adolescents aged 10–17 years (32 females, mean age: 14.09 years, SD: 2.1) were recruited in the Medical Faculty at Kiel University. Informed consent from the participants and their parents was obtained before the experiment. The exclusion criteria consisted of substance or medication consumption, implants and devices in the body, pregnancy, birth before pregnancy week 37, birth weight lower than 2500 grams, IQ score lower than 80 assessed with CFT 20-R Test (Culture Fair Intelligence Test)